---
title: 'Educational Exchange Program on AML'
published: true
date: '05-04-2024 10:00'
publish_date: '05-04-2024 10:00'
hide_page_title: false
show_sidebar: true
hide_git_sync_repo_link: false
---

The Hematology Center invites healthcare professionals specializing in the diagnosis and treatment of acute myeloblastic leukemia (AML) to participate in the educational program “Acute Myeloblastic Leukemia: From Theory to Practice.”

===

Date and Time:
May 22–24, 2024, from 08:00 to 17:00

Venue:
Karaganda, 17 Saken Seifullin Avenue, Hematology Center, Karaganda Branch

Within the framework of the program, participants will update their knowledge on the following topics:

Clinical features and diagnostic criteria of acute myeloblastic leukemias according to the WHO 2022 classification

Genetic risk group stratification based on ELN 2022

Interpretation of flow cytometry and molecular genetic testing results, including detection of FLT3 mutations

Prognostic significance of FLT3 mutations in hematology practice

Therapy selection in real-world clinical practice in accordance with ELN 2022 and NCCN 2024 recommendations

Local clinical protocols adapted to real-world practice, based on international guidelines and best global practices

The program is aimed at improving clinical practice in the management of patients with acute myeloblastic leukemia. It will include lectures, interactive workshops, and practical sessions with clinical case discussions and situational tasks.

Target Audience: Hematologists

We invite all interested specialists to join our program and enhance their professional expertise in the diagnosis and treatment of AML. The expected number of participants is up to 16, and the participation of physicians from neighboring countries is welcome.

Contact Person:
Akmarál Kanatovna Zhusupova
Phone: +7 701 303 2134

Program supported by: Novartis Pharma Services AG Branch in Kazakhstan